ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
Done
Inviting an author to review:
miRNA-21 is dysregulated in response to vein grafting in multiple models and genetic ablation in mice attenuates neointima formation
Find an author and click ‘
Invite to review selected article
’ near their name.
Search for authors
Search for similar articles
Invite by email
5
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,341
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
A randomized trial in patients with gemcitabine refractory pancreatic cancer. Final results of the CONKO 003 study
Author(s):
U Pelzer
,
K Kubica
,
J. Stieler
,
I Schwaner
,
G Heil
,
M Görner
,
M. Molle
,
A Hilbig
,
B Dörken
,
H Riess
,
H Oettle
Publication date:
2008
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Karger: Oncology
Data availability:
ScienceOpen disciplines:
Oncology & Radiotherapy
,
Medicine
Comments
Comment on this article
Sign in to comment
Similar content
2,341
A randomized trial in patients with gemcitabine refractory pancreatic cancer. Final results of the CONKO 003 study
Authors:
U Pelzer
,
K Kubica
,
J. Stieler
A randomized trial in patients with gemcitabine refractory pancreatic cancer. Final results of the CONKO 003 study
Authors:
KKU Pelzer
,
J. Stieler
,
I Schwaner
…
Oxaliplatin/folinic acid/5-fluorouracil [24h] (OFF) plus best supportive care versus best supportive care alone (BSC) in second-line therapy of gemcitabine-refractory advanced pancreatic cancer (CONKO 003)
Authors:
H Oettle
,
U Pelzer
,
J. Stieler
See all similar
Cited by
1
A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer
Authors:
C Yoo
,
J-Y Hwang
,
J. Kim
…
See all cited by